Dexcom Announces Upcoming Conference Presentations

Rhea-AI Summary

DexCom, Inc. (NASDAQ:DXCM) announced its participation in two upcoming investor conferences. Sean Christensen, Vice President of Finance and Investor Relations, will present at the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference on March 1, 2023, at 2:45 PM EST. Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present at the Raymond James 44th Annual Institutional Investors Conference on March 7, 2023, at 3:25 PM EST. Webcast links will be available on the Dexcom Investor Relations website and archived for future access.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:

• Sean Christensen, Vice President, Finance and Investor Relations, will present on behalf of the company at the Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference on Wednesday, March 1, 2023 at 2:45pm (EST).
• Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present on behalf of the company at the Raymond James 44^th Annual Institutional Investors Conference on Tuesday, March 7, 2023 at 3:25pm (EST).

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230223005174/en/

DexCom, Inc.

Sean Christensen

Vice President – Finance and Investor Relations

investor-relations@dexcom.com

(858) 200-0200

Source: DexCom, Inc.

FAQ

When is DexCom's presentation at the Citi 2023 Healthcare Services Conference?

DexCom's presentation at the Citi 2023 Healthcare Services Conference is on March 1, 2023, at 2:45 PM EST.

Who will represent DexCom at the Raymond James Institutional Investors Conference?

Jereme Sylvain, Executive Vice President and Chief Financial Officer, will represent DexCom at the Raymond James Institutional Investors Conference.

What is the stock symbol for DexCom, Inc.?

The stock symbol for DexCom, Inc. is DXCM.

Where can I find the webcast links for DexCom's investor presentations?

The webcast links for DexCom's investor presentations will be available on the Dexcom Investor Relations website.

What type of technology does DexCom focus on?

DexCom specializes in innovative continuous glucose monitoring (CGM) systems for diabetes care.